| U01FD006507 (USFDA) |
Impact of Formulation
Composition on the
Structure and
Performance Attributes
of Topical Products |
Dr. S.N Murthy
Topical Products
Testing LLC |
-- |
| U01FD007323
(USFDA) |
Progressing integration
of in vitro topical
formulation
characterization,
release, and
permeation data to the
next level - PBPK-based
extrapolation to
bioequivalence
assessment in virtual
populations |
Dr. Sebastian Polak
Certara UK Ltd |
Dr. S.N Murthy
Topical Products
Testing LLC |
| U01FD007954
(USFDA) |
Formulation toolbox
for topically applied
drugs to account for
physical parameters,
dynamic
metamorphosis, and
influence of excipients |
Dr. James Clarke,
SIMCYP LTD |
Dr. S.N Murthy
Topical Products
Testing LLC |
